Cargando…

1282. Ceftolozane/Tazobactam Use in Critically Ill Patients Receiving Intermittent or Continuous Renal Replacement Therapy

BACKGROUND: Our hospital recommends ceftolozane/tazobactam (CT) as a broad-spectrum agent for treatment of Gram-negative bacilli in patients with a recent or current multidrug resistant (MDR) Pseudomonas infection. CT is utilized in patients who are on renal replacement therapy (RRT) yet little data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henry, Molly, Puzniak, Laura A, Harris, Kelly, Van Schooneveld, Trevor C, Bergman, Scott J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644283/ http://dx.doi.org/10.1093/ofid/ofab466.1474

Ejemplares similares

609. Implementation of Bayesian Software for Vancomycin Dosing Integrated into an Electronic Medical Record
por: Jantrakul, Nicholas A, et al.
Publicado: (2021)

161. Flucytosine Utilization and Dosing Practices at an Academic Medical Center
por: Miller, Molly M, et al.
Publicado: (2021)

1480. Impact of a Guidance Document, Order Set Changes and Physician Education on Antibiotic Prescribing in Acute Exacerbation of COPD
por: Anderson, Jayme, et al.
Publicado: (2018)

178. Impact of a Best Practice Alert Linking Clostridium difficile Infection Test Results to a Severity-Based Treatment Order Set
por: Reed, Holly, et al.
Publicado: (2018)

2291. Evaluation of Multidrug-Resistant Pseudomonas aeruginosa Isolates in Patients Receiving Ceftolozane/tazobactam
por: Bodo, Emily C, et al.
Publicado: (2019)

A Novel Dosing Strategy of Ceftolozane/Tazobactam in a Patient Receiving Intermittent Hemodialysis
por: Shah, Sunish, et al.
Publicado: (2021)

Pneumonia panel results and antibiotic prescribing in COVID-19 patients in 2020 versus 2022
por: Hussain, Aysha, et al.
Publicado: (2023)

624. Significant Institutional Cost Savings from OPAT-Facilitated Discharge for Patients with Challenging Situations
por: Alexander, Bryan, et al.
Publicado: (2020)

Ceftolozane/tazobactam for the treatment of bacteremia: a systematic literature review (SLR)
por: Khankhel, Z. S., et al.
Publicado: (2022)

1023. Isavuconazonium Use at an Academic Transplant Center
por: Servais, Abigail, et al.
Publicado: (2019)

Real-world use of ceftolozane/tazobactam: a systematic literature review
por: Puzniak, Laura, et al.
Publicado: (2021)

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
por: Honore, Patrick M., et al.
Publicado: (2019)

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
por: Aguilar, Gerardo, et al.
Publicado: (2020)

1066. Antimicrobial Stewardship Program: Audit and Feedback for Continued Improvement
por: Wang, Joseph, et al.
Publicado: (2019)

126. evaluation of Addition of Outpatient Parenteral Antimicrobial Therapy and Orthopedic ID Resources to Transitions-of-care Outcomes
por: Young, Brett, et al.
Publicado: (2020)

Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
por: Aguilar, Gerardo, et al.
Publicado: (2019)

2200. Cost-effectiveness of Ceftolozane/Tazobactam for Treating Ventilated Nosocomial Bacterial Pneumonia
por: Naik, Jaesh, et al.
Publicado: (2019)

Ceftolozane-tazobactam in nosocomial pneumonia
por: Candel, Francisco Javier, et al.
Publicado: (2022)

Perioperative cefazolin prescribing rates following suppression of alerts for non-IgE-mediated penicillin allergies
por: Bogus, Ashley, et al.
Publicado: (2023)

Systematic Literature Review of Real-world Evidence of Ceftolozane/Tazobactam for the Treatment of Respiratory Infections
por: Puzniak, Laura, et al.
Publicado: (2021)

1612. Evaluation of the Use of Ceftolozane/Tazobactam for the Treatment of ESBL-producing Enterobacterales Infections Using International Data from SPECTRA (Study of Prescribing Patterns and Effectiveness of Ceftolozane/Tazobactam Real World Analysis)
por: Soriano, Alex, et al.
Publicado: (2020)

86. Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin
por: Watkins, Andrew B, et al.
Publicado: (2020)

Cefiderocol Activity Against Clinical Pseudomonas aeruginosa Isolates Exhibiting Ceftolozane-Tazobactam Resistance
por: Simner, Patricia J, et al.
Publicado: (2021)

Clinical and Safety Evaluation of Continuously Infused Ceftolozane/Tazobactam in the Outpatient Setting
por: Jones, Bruce M, et al.
Publicado: (2020)

Erratum: Ceftolozane-tazobactam in nosocomial pneumonia
por: FJ, Candel, et al.
Publicado: (2022)

1319. Pharmacokinetics of Ceftolozane/Tazobactam in Patients with Burns
por: Hall, Ronald G, et al.
Publicado: (2020)

A Multicenter Evaluation of Ceftolozane/Tazobactam Treatment Outcomes in Immunocompromised Patients With Multidrug-Resistant Pseudomonas aeruginosa Infections
por: Hart, Delaney E, et al.
Publicado: (2021)

Treatment of Asymptomatic Bacteriuria after Implementation of an Inpatient Urine Culture Algorithm in the Electronic Medical Record
por: Osiemo, Dianne, et al.
Publicado: (2021)

Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin
por: Watkins, Andrew B., et al.
Publicado: (2021)

988. Is There Value of Infectious Diseases Consultation in Candidemia? A Single Center Retrospective Review From 2016-2019
por: Ryder, Jonathan H, et al.
Publicado: (2021)

Antimicrobial stewardship: attempting to preserve a strategic resource
por: Van Schooneveld, Trevor
Publicado: (2011)

2248. Clinical and Microbiological Outcomes Associated with Real-World Use of Ceftolozane/Tazobactam
por: Cabrera, Nicolo, et al.
Publicado: (2019)

Impact of specialty on the self-reported practice of using oral antibiotic therapy for definitive treatment of bloodstream infections
por: Marcelin, Jasmine R., et al.
Publicado: (2023)

Rise of the (possible) resistance: a review of susceptibility patterns for nontyphoidal Salmonella enterica in Nebraska
por: Sunagawa, Shawnalyn W., et al.
Publicado: (2023)

2055. Action: A Year in the Lives of Consultant Pharmacists Working on Antimicrobial Stewardship in Long-Term Care Facilities
por: Chung, Philip, et al.
Publicado: (2019)

289. Impact of Clinician Specialty on the Use of Oral Antibiotic Therapy for Definitive Treatment of Uncomplicated Bloodstream Infections
por: Marcelin, Jasmine R, et al.
Publicado: (2020)

Beta‐lactam allergies, surgical site infections, and prophylaxis in solid organ transplant recipients at a single center: A retrospective cohort study
por: Mowrer, Clayton, et al.
Publicado: (2022)

2194. Implementation of the CDC’s Core Elements of Antibiotic Stewardship: A Survey of Long-Term Care Facilities During the COVID-19 Pandemic
por: Cichon, Catherine (Cathy), et al.
Publicado: (2023)

Ceftolozane-tazobactam: When, how and why using it?
por: López, Inmaculada, et al.
Publicado: (2021)

Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction
por: Sime, Fekade B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m98dohd6p2982p4ucu6je29kkj